"Mildronat" Akala a

e hoʻohana 'ia "Mildronat" o na papa io no ka kela naau maʻi, i waena a he kūikawā wahi ua ku e myocardial infarction, angina, maʻi circulatory ole. Ka mea, i kekahi mana like me ka hoʻohui pū Inc o ka hahauʻana, cerebrovascular insufficiency. Ka lāʻau i loko o ka hui pu ana me kekahi Luna no ka iapaau ana o ka alcoholism ua hoʻohana 'ia e hoʻopau i ka ole ana, alaila maʻi pale. "Mildronat" Akala a mea he pono ka mea e hoʻopau physical stress, e hoihoi functionality.

Kēia lāʻau, he cardioprotective, antianganalnym, antihypoxic, angioproteguoe hana. Ma na kumu o ka kiʻekiʻe lāʻau wahie, e hooponopono i kaulike ma waena o haawi a me ke koi ana o myocardial keena o ka o oxygen ua ālai 'ka hoʻomāhuahua o pathological metabolic huahana, penei, i malama na nā loko, mai poho, iaono? Ienoai kino leo. "Mildronate" papa noho vasoconstrictive waiwai. I ka hopena o keia hana mea e emi i ka loli wahi i loko o myocardial infarction. I ka maʻi naau hoʻokō 'ole' lāʻau hoʻokāʻoi aʻe ana i kona contractile hana, maoli ia'ku i physical stress.

E hoomakaukau ai "Mildronate" maupaʻa meldonium (ʻeleu waiwai), a mea he mea like o ka luna 'hui gamma-butyrobetaine, a ua loaʻa i loko o nā mea a pau kanaka keena.

Ka lāʻau i ke kiʻekiʻe kiʻekiʻe o ka bioavailability. Nō hoʻi ia i ke kiʻekiʻe omo kaʻi lau waiwai i loko o ka gastrointestinal'āpana. ʻO kā mākou lehulehu malama, elua no hora ma hope o kaʻaiʻana. Ka lāʻau 'Ua excreted i loko o ka mimi hope pūnao i ka hana puʻupaʻa ma hope o eono hola. Me ka hoʻoulu nā māhele o ka huahelu, pakahi, maoli.

"Mildronat" na papa, olelo ao no ka i hoʻomōakaaka a pau na nāʻikepili a dosing kāu kiʻina hana i kekahi mau contraindications: hypersensitivity i ka eiiiiiaiou, mahuahua intracranial puʻe loina. Ka hope complication malama ma ka 'aʻe o ka outflow o venous koko, lolo hikoko. Unanswered nīnau koe i ka maluhia o ka lāʻau i hāpai keiki, lactation. No ia mea, i Inc me keia k e hooki lakou umauma-e ai ana.

Ma kekahi mau hihia, i ka wa e loaa ana "Mildronate" malama i keʻano o allergic-type reactions (ka ohane, rashes, hoʻokano, redness), dyspeptic symptoms, tachycardia, loli i loko o ke koko,, manaʻo pīhoihoi.

I ka wa ana i kēia huahana e lawe me ka waiwai o nā pharmacological pūʻulu i mooolelo hana kūleʻa. Ua hoʻokāʻoi aʻe ana i ka hopena o ke dala koronadilatiruyuschego hana. Nō hoʻi me ka nui loa ho'ēmi i kā ka puʻe i loko o ka palapala noi me ka antihypertensive ai '. A me ka hui pu ana o ka anticoagulant, antianginal ai ', antiarrhythmic ai', antiplatelet konohiki, diuretics, bronchodilators. pono e lawe malama wā hoʻohana i ka huipūʻana me kaʻike ākea vasodilators, antihypertensive konohiki, Alpha-blockers, nifedipine, nitroglycerin, no ka mea, i loko o keia hihia e hoʻomōhala hypotension a me ka lōpū tachycardia. Ka wā e like 'ole mai ka hoʻohana no ka hana maikaʻi lāʻau "Mildronate" (papa). Na Ke Kumu no ka hoʻohana ana i ka lāʻau 'aʻole i ke koho' ia i ka hopena o ka overdose, no ka mea, ua i kākau ia hihia. Information e pili ana i ka laulā o ka pono o nā keiki like ole. Ke holopapa ola o ka lāʻau, he eha makahiki, houʻeleu waiwai haalele i kona pharmacological waiwai a me maoli i ka manawa kūpono o ka pilikiaʻaoʻao loa.